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The ciliary margin (CM) develops in the peripheral retina and gives rise to the iris and the ciliary body.
The Wnt/β-catenin signalling pathway has been implicated in ciliary margin development. Here, we
tested the hypothesis that in the developing mouse retina Foxg1 is responsible for suppressing the
Wnt/β-catenin pathway and restricting CM development. We showed that there is excess CM tissue in
Foxg1−/− null embryos and this expansion is more pronounced in the nasal retina where Foxg1 normally
shows its highest expression levels. Results on expression of a reporter allele for Wnt/β-catenin signalling
and of Lef1, a target of Wnt/β-catenin signalling, displayed signiﬁcant upregulation of this pathway in
Foxg1−/− nulls at embryonic days 12.5 and 14.5. Interestingly, this upregulation was observed speciﬁcally
in the nasal retina, where normally very few Wnt-responsive cells are observed. These results indicate a
suppressive role of Foxg1 on this signalling pathway. Our results reveal a new role of Foxg1 in limiting
CM development in the nasal peripheral retina and add a new molecular player in the developmental
network involved in CM speciﬁcation.
& 2013 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
During eye development the optic cup gives rise to the centrally
located neural retina (NR), an outer located layer known as retinal
pigment epithelium (RPE) and to the peripherally located ciliary
margin (CM), which lies at the interface between the NR and the
RPE. Although of neural origin, the CM generates two non-neural
epithelial eye structures: the ciliary body (CB) proximally, which is
responsible for the production of the aqueous humor and mainte-
nance of the intraocular pressure, and the iris distally, whose role is to
control the amount of light entering the eye and the circulation of the
aqueous humor (reviewed in Davis-Silberman and Ashery-Padan,
2008). The study of the molecular properties of the CM has drawn
a lot of attention, in part because mutations in genes responsible for
its formation are associated with an increased risk of glaucoma
(Gould et al., 2004; Hannenhalli and Kaestner, 2009).
Several pieces of evidence have implicated the Wnt/β-catenin
signalling pathway in CM development in both chicks and mice
(Cho and Cepko, 2006; Esteve et al., 2011; Fuhrmann et al., 2009;ublished by Elsevier Inc. All rights
r the terms of the Creative
tricted use, distribution, and
thor and source are credited.
T. Pratt),Liu et al., 2003, 2006, 2007). Among the multiple members of theWnt
family of morphogens, Wnt2b shows a characteristic expression
pattern in the CM (Jasoni et al., 1999; Kubo et al., 2003; Liu et al.,
2003) and has been implicated in CM fate speciﬁcation (Cho and
Cepko, 2006). Reporter mice for the Wnt/β-catenin signalling pathway
and chicks electroporated with a Wnt signalling reporter have
revealed that this pathway is active in the CM and RPE (Cho and
Cepko, 2006; Fuhrmann et al., 2009; Liu et al., 2006). In agreement
with this, downstream targets of Wnt signalling such as Lef1 and
Axin2 have also been shown to be expressed in these structures
(Burns et al., 2008; Fuhrmann et al., 2009; Kubo et al., 2003; Liu et al.,
2006). Furthermore, a mouse strain that expresses a constitutively
active form of β-catenin in the peripheral retina promotes CM
development at the expense of NR, while conditional inactivation of
the β-catenin gene in the retina leads to disrupted development of the
CM (Liu et al., 2007). These data indicate that Wnt/β-catenin signalling
is required for and promotes normal CM development. So far,
however, there is no information regarding the factor or factors that
limit the development of this eye structure.
Foxg1 is a transcriptional repressor (Marcal et al., 2005; Yao
et al., 2001) essential for mouse survival (Xuan et al., 1995). It is
mainly expressed in the developing telencephalon, hypothalamus,
optic chiasm and retina (Dou et al., 1999; Fotaki et al., 2006; Hatini
et al., 1994; Huh et al., 1999; Marcus et al., 1999; Pratt et al., 2004;
Tao and Lai, 1992; Tian et al., 2008; Xuan et al., 1995). Foxg1's role
in the developing telencephalon has been studied extensively and
different reports have shown that this protein is required forreserved.
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Hanashima et al., 2007; Hanashima et al., 2004; Manuel et al.,
2011; Martynoga et al., 2005; Xuan et al., 1995). In addition, Foxg1
is essential for proper telencephalic patterning (Danesin et al.,
2009; Dou et al., 1999; Manuel et al., 2010; Martynoga et al., 2005).
Less is known about the role of Foxg1 in the developing eye.
Null mutants for Foxg1 (Foxg1−/−) have micropthalmic eyes with
a large ventral coloboma (Huh et al., 1999; Xuan et al., 1995).
Foxg1−/− retinas display abnormal folds and lack an obvious optic
stalk structure (Huh et al., 1999). However, they retain normal
layering of the retina (Huh et al., 1999) and have a similar number
of retinal ganglion cells (RGCs) to that of control littermates (Pratt
et al., 2004; Tian et al., 2008).
Foxg1 has been implicated in diverse signalling pathways
responsible for dorso-ventral telencephalic patterning including
those of Tgf-β, Bmp, Wnt, Shh and Fgf (Danesin et al., 2009; Dou
et al., 2000, 1999; Martynoga et al., 2005). In the zebraﬁsh
telencephalon, foxg1 has been shown to repress the Wnt/β-catenin
pathway by direct binding to wnt8b, limiting pallial cell identities
(Danesin et al., 2009).
Here, we have examined the hypothesis that in the developing
mouse retina Foxg1 is responsible for suppressing the Wnt/β-
catenin pathway and restricting the development of CM tissue.
We show that CM tissue is expanded in Foxg1−/− null embryos and
this expansion is more pronounced in the nasal retina where Foxg1
normally shows its highest expression levels. Foxg1−/− nulls
crossed to a reporter mouse for Wnt/β-catenin signalling display
a signiﬁcant upregulation of this pathway at embryonic day
(E) 12.5 and E14.5. Interestingly, this upregulation is observed
speciﬁcally in the nasal retina, where normally very few
Wnt-responsive cells are observed. These results indicate a sup-
pressive role of Foxg1 on this signalling pathway. Our results
reveal a new role of Foxg1 in maintaining the normal size of the
CM in the nasal peripheral retina and add a new molecular player
in the developmental network involved in CM speciﬁcation.Materials and methods
Animals
Mice were maintained, bred and handled according to Home
Ofﬁce (UK) regulations.
The following mouse lines were used for this study: a Foxg1-lacZ
heterozygous strain (Xuan et al., 1995) kept on an F1 back-
ground (CBAxC57/B6); a Foxg1-cre heterozygous strain (Hebert and
McConnell, 2000) kept on an F1 background; a BAT-gal reporter strain
(Maretto et al., 2003) kept on a C57/B6 background was crossed to the
Foxg1+/cre mouse to generate compound Foxg1-cre heterozygous/BAT-
gal mutants. For the GFP expression experiment, a Gsh2-cre strain
(Kessaris et al., 2006) was crossed to the Foxg1+/lacZ mouse carrying a
GFP reporter allele (Sousa et al., 2009). Heterozygous mice were
genotyped as described in the corresponding references. They were
intercrossed to generate homozygous mutants which were identiﬁed
by phenotyping (Foxg1−/− and Foxg1−/−;GFP+ mutants) and genotyping
(BAT-gal+;Foxg1−/− mutants).
As no differences were detected between wild types (Foxg1+/+)
and heterozygotes (Foxg1+/−) these embryos were both used in the
control group.
The day the vaginal plug was detected was designated as
embryonic day (E) 0.5.
Histology, immunohistochemistry, immunoﬂuorescence
Embryos were collected and ﬁxed in 4% paraformaldehyde in
0.1 M phosphate buffer, pH 7.4. They were processed for parafﬁnor cryostat embedding according to previously described protocols
(Fotaki et al., 2011, 2008, 2006).
Immunohistochemistry and immunoﬂuorescence were carried
out as previously described (Fotaki et al., 2008, 2006). The following
antibodies were used in this study: (A) rabbit polyclonals: β-gal
(1:1000, Invitrogen, Molecular Probes); Lef1 (1:1000, Cell Signal-
ling); Mitf (1:1000, kindly provided by Prof H. Arnheiter); Sox2
(1:3000, Millipore); Vsx2 (1:1000, kindly provided by Prof C.L.
Cepko); (B) mouse monoclonals: Cyclin D1 (1:5000; ab140302
Abcam); Otx1 (1:50, DSHB); Pax6 (1:200, DSHB); (C) a goat
polyclonal GFP (1:1000, ab6673 Abcam); (D) a rat monoclonal BrdU
(1:200; ab6326 Abcam).
In situ hybridisation
In situ hybridisation was performed as previously described
(Wallace and Raff, 1999). Riboprobes were synthesised using the
DIG-labelling system according to the manufacturer's protocol
(Roche). The following mouse riboprobes were used in this study:
Bmp4, Tbx5 and Vax2 (kindly provided by Dr R. Hindges); Foxg1
and Wnt2b (kindly provided Dr T. Theil); Msx1 (kindly provided by
Dr L. Lettice); Lef1 (kindly provided by Dr O. Machon) and Sfrp2
(kindly provided by Dr A. Rattner).
Imaging
DAB and in situ images were taken with a Leica DFC480 camera
connected to a Leica DMNB epiﬂuorescence microscope. Fluores-
cence images were taken with a Leica DM5500B automated
upright microscope connected to a DFC360FX camera. Confocal
images were taken with a Zeiss LSM510 confocal system coupled
to a Coherent Mira mode-locked Ti:Sapphire multi-photon laser.
Cell counts
The labelling index (LI) was calculated as the ratio of BrdU-
positive to total number of cells on E11.5 control and mutant
sections. Pregnant females were injected with 50–70 mg/kg BrdU
(10 mg/ml in 0.9% NaCl, i.p.) and sacriﬁced 30 min later. Cell
counts were performed within three 50 mm bins, placed along the
peripheral retina and were the average of at least six control and
four mutant 10 mm thick sections. A total of three eyes from two
different specimens were used for each genotype.
A one way ANOVA was used to calculate statistical differences
in the LI between bins of the same genotype. A student's t-test was
used to calculate statistical differences between corresponding
bins of controls and mutants. Differences were considered
signiﬁcant for P values ≤0.01.
Total numbers of β-gal-positive cells were counted along the
entire retina on consecutive 10 μm thick sections 30 μm apart.
A total of 6 eyes from 3 different specimens were used for each
genotype.
Numbers of nasal and temporal β-gal-positive cells were
counted on consecutive 10 mm thick horizontal sections 30 mm
apart. The most dorsal and ventral sections, where the nasal and
temporal retina could not be deﬁned with precision, were
excluded from the counts. A total of 6 eyes from 3 different
specimens for controls and 4 eyes from 2 different specimens for
mutants were used.
Lef1-immunopositive cells were the average from two conse-
cutive 10 μm thick sections, 30 μm apart, counted in the nasal
peripheral retina of 3 control and 3 mutant eyes.
A non-parametric test (Mann-Whitney) was used to calculate
statistical differences between control and Foxg1−/− mutant total,
nasal, and temporal β-gal-positive cells and Lef1-positive nasal
cells. Differences were considered signiﬁcant for P values ≤0.01.
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Foxg1 retinal expression
We had previously described high expression of Foxg1 in
the dorsal and nasal retina at embryonic day (E) 14.5, based onFig. 1. Foxg1 retinal expression is graded from highnasal-to-low temporal. In situ hybridisa
(A–E). (F) and (G) are low power images of (A) and (C) respectively. (H) and (I) are high p
the approximate position of the ciliary margin (CM) N –4 T in this and subsequent ﬁg
chiasm; oe, olfactory epithelium; r, retina; Tel, telencephalon. Scale bars: A–E, 100 μm;beta-galactosidase (β-gal) expression in Foxg1lacZ/+ heterozygous
embryos (Pratt et al., 2004; Tian et al., 2008). Here, we examined
the retinal expression pattern of the Foxg1 transcript by in situ
hybridisation at E12.5 (Fig. 1). Our results show Foxg1 expression
in the form of a highnasal-to-lowtemporal gradient (Fig. 1A–E). Also
Foxg1 is less intensely expressed in the most ventral retinaltion of Foxg1 on consecutive dorsal (D) to ventral (V) retinal E12.5 wild type sections
ower images of the squared areas in (C). The dashed brackets in (H) and (I) indicate
ures indicates the nasal-temporal axis. Abbreviations: Hy, hypothalamus; oc, optic
F, G, 800 μm; H, I, 50 μm.
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Similar results were obtained at E14.5 (data not shown). High
power images show that the strong Foxg1 expression nasally
extends to the distal edge of the retina, where the ciliary margin
(CM) is located (Fig. 1H). In temporal sections, Foxg1 expression,
although detectable, was not very strong and probably does not
stain all CM cells (Fig. 1I). The overall expression level of Foxg1 in
the eye was lower than that in the forebrain (compare intensity of
staining in the eye with that in the optic chiasm and telencephalon
in sections 1F and 1G) and this was conﬁrmed quantitatively by
RT-qPCR (data not shown).Morphology of the Foxg1−/− retina
During eye development the Foxg1−/− optic cup fails to close at
the optic ﬁssure leading to a large ventral coloboma and the retina
elongates abnormally (Huh et al., 1999). As development
progresses, the Foxg1−/− retina becomes severely distorted making
it difﬁcult to interpret its phenotype. To gain insight into the
gradual alterations of the Foxg1−/− retina and understand its
morphology, we examined horizontal sections of Foxg1−/− and
control littermates at E11.5 and E12.5 using in situ hybridisation
for Sfrp2. At E11.5, Sfrp2 labels most retinal cells both in controls
and Foxg1−/− mutants (Fig. 2A–E′). At this stage, both the nasal and
temporal retinal pigment epithelium (RPE) have developed
in controls, surrounding the entire retina (Fig. 2A–E). In Foxg1−/−
mutants, the RPE surrounds both the nasal and temporal retina
in only the most dorsal sections (Fig. 2A′–B′), whereas in middle
and ventral sections only its temporal component is present
(Fig. 2C′–E′). As both the nasal and temporal mutant RPE are
present at E12.5 (Fig. 2F′–L′), the defect we observe at E11.5
reﬂects a developmental delay in the formation of nasal eye
components.
In E12.5 control sections, Sfrp2 labels all retinal cells in the
proliferating layer and most of the retinal ganglion cells (RGCs) of
the differentiating layer of the central retina (Fig. 2F–I) (Leimeister
et al., 1998). However, Sfrp2 staining is not observed in the CM
(Fig. 2G,H and Liu et al., 2003). Consecutive dorsal-to-ventral
Foxg1−/− mutant sections labelled with Sfrp2 reveal that, unlike
the control, the mutant optic cup is not spherical (Fig. 2G′–L′).
In addition, the opening of the optic cup containing the lens is only
visible in the most ventral sections (Fig. 2J′,K′). This may be
a consequence of the retina not growing properly along the
nasal-temporal axis (the axis perpendicular to the optic stalk in
controls), due to failure of the mutant optic ﬁssure to seal.
To study whether the abnormal Foxg1−/− retina shows defects in
patterning, we studied expression of Bmp4 and Tbx5, which are
normally found in the dorsal optic cup, and Vax2, which is
normally expressed ventrally (Behesti et al., 2006). Our results
did not reveal any signiﬁcant differences between controls and
Foxg1−/− mutants in the patterns of expression of these markers
(Suppl Fig. 1), in agreement with previous ﬁndings using other
patterning molecules in these mutants (Pratt et al., 2004).
In summary, by E12.5, the defects observed at E11.5 become
accentuated, with an obvious distortion of the normal spherical
morphology of the mutant optic cup. At this stage, abnormal
retinal folds are clearly detected nasally (Fig. 2G′–I′).
In addition to the above general morphological differences
between controls and Foxg1−/− mutants in the shape of the
developing optic cup and retina, Sfrp2 in situ hybridisation at
E12.5 revealed additional Sfrp2-negative areas in mutants (com-
pare Fig. 2G,H to H′-K′ and Fig. 3 below). These Sfrp2-negative
areas are located predominantly nasally (see bracket and dashed
line in Fig. 2H′), where Foxg1 expression is normally highest.Ciliary margin tissue expansion in the Foxg1−/− mutant
At E12.5, several molecules such as Otx1, Mitf and Wnt2b are
expressed in the peripheral but not the central retina (Amae et al.,
1998; Horsford et al., 2005; Liu et al., 2003; Martinez-Morales
et al., 2001; Trimarchi et al., 2009). To conﬁrm the presence of
additional CM tissue in the Foxg1−/− retina, suggested by the
expanded Sfrp2-negative staining (Fig. 2), we examined expression
of Mitf protein in E12.5 sections and compared it to the Sfrp2-
negative domain.
In control sections, Mitf is speciﬁcally expressed in the RPE and
at the tips of the CM (Fig. 3A and Amae et al., 1998; Horsford et al.,
2005), in a region of the retina which does not express Sfrp2
(compare positive staining in Fig. 3A with negative stained regions
in Fig. 3B). In the Foxg1−/− retina, expression of Mitf is also detected
in the RPE and the tips of the CM as in controls (Fig. 3A′). However,
the domains of Mitf expression are increased (Fig. 3A′) and
coincide with the additional Sfrp2-negative regions (compare
positive staining in Fig. 3A′ with negative stained regions in
Fig. 3B′). Mitf staining in the Foxg1−/− RPE appears normal.
To provide additional evidence of the expansion of CM tissue in
the Foxg1−/− retina, we examined expression of Cyclin D1 and Sox2
(Fig. 3C–D′), two proteins which are both normally absent from the
CM region (Liu et al., 2007; Matsushima et al., 2011; Taranova
et al., 2006). Immunohistochemistry for these markers revealed an
expansion in both the Cyclin D1-negative (Fig. 3C′) and Sox2-
negative (Fig. 3D′) domains of expression in the Foxg1−/− mutant,
in agreement with the results observed with Sfrp2 (Fig. 3B′).
Sox2 displays an inverse pattern of expression in the develop-
ing optic cup to that of Pax6 protein, with high expression of Sox2
in the central and of Pax6 in the peripheral retina (Matsushima
et al., 2011). Double immunoﬂuorescence for these proteins at
E12.5, shows an expansion in the Pax6-highly-expressing; Sox2-
negative domain of expression in Foxg1−/− mutants (Suppl Fig. 2A′–C′)
compared to controls (Suppl Fig. 2A–C), further conﬁrming that the
enlarged Sox2-negative domain in mutants corresponds to CM-like
tissue.
It has been shown that the peripheral retina has lower
proliferation rates compared to the central retina (Fischer and
Reh, 2000; Kubota et al., 2004; Liu et al., 2007). To substantiate
that the expanded region in Foxg1−/− mutants corresponds to
CM-like tissue not only in terms of marker expression but also in
terms of cellular behaviour, we examined the BrdU labelling index
(LI) of the peripheral retinal region in controls and mutants. We
performed this study at E11.5, when the morphological differences
between Foxg1−/− and control retinas are not as severe as those
observed at later developmental stages (Fig. 4). We performed cell
counts on serial sections (Fig. 4A,A′), using three consecutive cell
counting bins placed at the peripheral retina, which was immu-
nopositive for the CM marker Otx1 (Fig. 4B,B′). Our results
revealed that in both control and Foxg1−/− mutant sections the LI
of bin 1 (most peripheral) was signiﬁcantly different to the LI of
bins 2 and 3 (Fig. 4C). In addition, the LI of Foxg1−/− mutants was
signiﬁcantly reduced compared to that of controls in all areas
studied (Fig. 4C), in agreement with the role of Foxg1 as a
regulator of cell proliferation (Martynoga et al., 2005; Xuan
et al., 1995). These results conﬁrm that the peripheral retina in
Foxg1−/− mutants, as deﬁned by expression of Otx1, shows cell
cycle properties of CM-like tissue.
After E12.5 the Foxg1−/− mutant retina begins to elongate.
We examined how the CM region develops in these mutants at
E14.5, using Mitf, which labels the RPE and the tip of the CM in
control embryos (Fig. 5A,A′). We took advantage of a ﬂoxed-GFP
reporter allele (Sousa et al., 2009; see Material and Methods for
details) and a Gsh2Cre allele (Kessaris, et al., 2006) whose combi-
nation labels the RPE and the entire CM region of controls at E14.5
Fig. 2. The morphology of the Foxg1−/− mutant optic cup displays severe abnormalities. In situ hybridisation for Sfrp2 in control (Foxg1+/+) (A–E; F–I) and mutant (Foxg1−/−) (A
′-E′; F′-L′) on consecutive dorsal (D) to ventral (V) E11.5 (A–E′) and E12.5 (F–L′) horizontal eye sections. Arrows in (B), (B′) and (C′) indicate the retinal pigment epithelium
(RPE). The dotted square in (B) demarcates the high power inset, which allows the RPE to be distinguished from the strong Sfrp2 retinal staining. The dashed lines in (C′–E′)
indicate the area of the optic cup that is not yet surrounded by RPE. Curly brackets in (D,D′) indicate the optic stalk (OS). The small-gapped dashed line in (D′) demarcates the
continuation of tissue that is Sfrp2-negative. Brackets (H,H′,I′) demarcate Sfrp2-negative regions, which correspond to ciliary margin tissue. Arrows in (H′) point to the retinal
pigment epithelium, which, by E12.5, surrounds the entire mutant optic cup, in both the temporal and nasal parts. Abbreviations: l, lens. Scale bar in (A) corresponds to
100 μm and applies for all panels (A–L′).
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and at the most distal tip of the CM (Fig. 5A–D, A′–D′). However,
GFP also labels the rest of the CM, which is negative for Mitfexpression, thus allowing us to distinguish between RPE and
entire CM tissue. In the Foxg1−/− mutants, Mitf is found in the
RPE and at the edges of the peripheral retina (Fig. 5E). Similar to
Fig. 3. Additional ciliary margin (CM) tissue in Foxg1−/−E12.5 mutants. Immunoﬂuorescence for Mitf in controls (Foxg1+/+) (A) and mutants (Foxg1−/−) (A′). In situ
hybridisation for Sfrp2 in controls (B) and mutants (B′). Immunohistochemistry for Cyclin D1 in controls (C) and mutants (C′) and for Sox2 in controls (D) and mutants (D′).
Images (A–A′) are counterstained with DAPI (blue staining) and (C–C′) with cresyl violet. Sections (A,A′) are adjacent to sections (B,B′) respectively and (C,C′) to (D,D′)
respectively. Squared areas in panels (A–B′) are depicted in a high power image to the right of each panel. Curly brackets indicate ciliary margin sites. Scale bars: (A–B′) low
power images, 100 μm; high power images, 50 μm; (C–D′), 100 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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most peripheral retina that surrounds the lens, which corresponds
to CM (Fig. 5F). However, GFP-positive cells are also observed
at the edges of the folded retina (Fig. 5F–H, F′–H′; curly bracketsin Fig. 5H). These GFP-positive sites express Mitf only at their
tips, while the rest of the GFP-positive area is Mitf-negative
(Fig. 5E,E′,H,H′), indicating that they correspond to CM, rather
than RPE.
Fig. 4. The cell cycle properties of the Foxg1−/− peripheral retina resemble those of CM-like tissue. Immunohistochemistry for BrdU (A,A′) and Otx1 (B,B′) in E11.5 control
(Foxg1+/+) (A,B) and mutant (Foxg1−/−) (A′,B′) horizontal retinal sections. Sections in (A,A′) are counterstained with cresyl violet. The counting bins used to calculate the
labelling indices are shown in red; green dots represent the labelled BrdU-positive cells and pink dots the unlabelled cells (cresyl violet-positive) (A,A′). The labelling indices
(fraction of BrdU-positive cells during a 30 min period) are plotted as average values from at least 3 different wild type (Foxg1+/+) and mutant (Foxg1−/−) retinas (C). The
labelling indices were calculated within three consecutive counting bins in the peripheral retina (Bin 1 corresponds to the most peripheral bin). Error bars indicate standard
deviation. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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labels the CM region throughout development (Fig. 6A,A′ and
Martinez-Morales et al., 2001; Trimarchi et al., 2009) and Vsx2,a marker of retinal progenitors (Fig. 6B,B′ and Liu et al., 1994).
In Foxg1−/− mutants, Otx1 expression was observed at the distal edges
of the retina that ﬂank the lens with a clear CM identity (Fig. 6A′).
Fig. 5. Evidence for additional ciliary margin (CM) sites in E14.5 Foxg1−/− retinas. Immunoﬂuorescence for Mitf (red) (A,A′,E,E′) and GFP (green) (B,B′,F,F′) in E14.5 horizontal
retinal sections. Mitf is expressed in the retinal pigment epithelium (RPE) and in the most anterior tip of the control CM (A,A′). Strong GFP staining is found in the RPE and
the entire CM of controls (B,B′). GFP and Mitf overlap in the RPE and partially overlap in the control CM (D,D′). In the null Foxg1−/− retina there is Mitf staining in the RPE and
the tips of the CM (E,E′) and intense GFP staining in the RPE and the entire CM (F,F′). Additional sites of GFP expression are found near the retinal folds (curly brackets in H,H
′). These GFP-positive sites only partially express Mitf (E,E′). (C,C′) and (G,G′) are the control and mutant sections respectively counterstained with DAPI (blue). Panels (A′–D′)
and (E′–H′) are high power images of the squared areas in (B) and (F) respectively. The dashed lines in (A) and (E) indicate the nasal (N) – temporal (T) divide in the control
and the Foxg1−/− mutant respectively. Scale bar in (A) corresponds to 200 μm and applies for panels (A–D) and (E–H). Scale bar in (A′) corresponds to 50 μm and applies for
panels (A′–D′) and (E′–H′).
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Fig. 6. Additional ciliary margin (CM) tissue in E14.5 Foxg1−/− retinas. Otx1 protein expression in the ciliary margin (CM) of control (Foxg1+/+) (A) and mutant (Foxg1−/−)
(A′) retinas, indicated by brackets. In Foxg1−/− mutants, additional sites of Otx1 expression surround retinal folds (curly brackets in A′). Immunostaining for Vsx2 in controls
(B) and mutants (B′) revealing normal retinal progenitor proliferation, even in the mutant folds. Msx1 mRNA expression in the CM of control and mutant retinas is in
agreement with that of Otx1. Msx1 is found in the CM margin of controls (C) and mutants (C′) and in additional sites in mutants (C′′). The Msx1 positive sites correspond to
the indicated sites in panels A (for C) and A′ (for C′, and C′′). The dashed lines in (A) and (A′) indicate the nasal (N) – temporal (T) divide in the control and the Foxg1−/− mutant
respectively. Abbreviations: l, lens. Scale bar in (A) corresponds to 200 μm and applies for panels (A–B′). Scale bar in (C) corresponds to 25 μm and applies for panels (C–C′′).
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retinal folds (curly brackets in Fig. 6A′), in similar positions to
those where GFP-positive cells were located (compare Figs. 5H′
to 6A′). Vsx2 was expressed in the proliferative retinal layer
in Foxg1−/− mutants (Fig. 6B′) as in controls (Fig. 6B) and expres-
sion continued into the folds conﬁrming their retinal identity
(Fig. 6B′).
Msx1, another CM marker (Monaghan et al., 1991) was found in
the CM of controls (Fig. 6C) and Foxg1 −/− mutants (Fig. 6C′), as wellas in sites located nasally in the mutant, away from the discernible
CM (Fig. 6C′′), in a similar fashion to that observed with Otx1
staining (compare Fig. 6C with the Otx1-positive region indicated
as C in Fig. 6A and C′ and C′′ with the sites indicated with the same
letters in Fig. 6A′.)
The above data collectively show that already at E12.5 there is
an abnormal expansion of CM tissue in the nasal retina of Foxg1−/−
nulls and this expansion becomes more pronounced at later stages
of development.
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embryos
Wnt2b and the canonical Wnt pathway have been implicated
in the development of the CM in both chicks and mice (Cho and
Cepko, 2006; Esteve et al., 2011; Fuhrmann et al., 2009; Kubo et al.,
2003; Liu et al., 2003, 2006, 2007). We tested the hypothesis that
Foxg1 normally suppresses the Wnt/β-catenin pathway. For this,
we used E12.5 compound mutant embryos for Foxg1−/− and the
BAT-gal reporter, which carries β-gal under a TCF/LEF promoter
and reports on Wnt/β-catenin signalling (Fotaki et al., 2011;
Maretto et al., 2003) (BAT-gal+;Foxg1−/− mutants and control
littermates BAT-gal+;Foxg1+/+ or BAT-gal+;Foxg1+/−).
We ﬁrst examined how expression of Wnt2b and that of the
downstream Wnt/β-catenin signalling target Lef1, shown to be
expressed in the peripheral retina (Liu et al., 2003, 2006), differed
between E12.5 controls and BAT-gal+;Foxg1−/− mutants.Fig. 7. Upregulation of Wnt/β-catenin signalling in the nasal ciliary margin (CM) of E1
studied by in situ hybridisation forWnt2b (A–B′′) and Lef1 (C–D′′) followed by immunohis
(B–B′′and D–D′′). Immunohistochemistry for Lef1 in controls (E,E′) and Foxg1−/− mutant
temporal (T) side of the same eye. The curly brackets in (B) and (D) indicate the nasal ret
squares indicated the temporal retina shown in high power in panels (B′′) and (D′′) respe
in the temporal mutant retina. The dotted square in (F) delineates the high power im
β-galactosidase (magenta) (H) and Pax6/β-galactosidase (I) on E12.5 BAT-gal+; Foxg1−/−
panels (A,A′,B′,B′′,C,C′,D′,D′′,E,E′,F′); (B,D,F), 100 μm; (G–I), 20 μm. Abbreviations: l, lens.In controls, Wnt2b expression is detected in the RPE and is
restricted to the tips of the CM in both the nasal (Fig. 7A) and
temporal retina (Fig. 7A′). As with controls, Wnt2b is detected in
the RPE and both the nasal (Fig. 7B,B′) and temporal CM of
mutants (Fig. 7B′′). However, Wnt2b is not only detected in the
nasal tip of the CM (Fig. 7B) but it is also strongly detected in the
retinal folds, which form nasally (curly bracket in Fig. 7B, B′).
Expression in the temporal tip of the CM seems to expand
compared to controls (compare Fig. 7A′ with Fig. 7B′′).
In contrast to Wnt2b, Lef1 expression is not restricted at the tip
of the control CM, but extends throughout the peripheral retina
both nasally (Fig. 7C) and temporally (Fig. 7C′), in a speckled
fashion, consisting of expressing and non-expressing cells. Lef1
expression in mutants is observed in the nasal (Fig. 7D,D′) and
temporal (Fig. 7D′′) CM. Similar to controls, Lef1 expression in
Foxg1−/− retinas displays a broader domain to that ofWnt2b. This is
clearly appreciated in the folded areas, where Wnt2b is restricted2.5 BAT-gal+; Foxg1−/− compound mutants. Horizontal E12.5 retinal sections were
tochemistry for β-galactosidase (β-gal) in controls (A,A′,C,C′) and compound mutants
s (F–F′). Panels (A,B′,C,D′,E,F′) correspond to the nasal (N) and (A′,B′′,C′,D′′,E′) to the
inal folds shown in high power in panels (B′) and (D′) respectively, while the dotted
ctively. The arrow in (D′′) indicates the start of the retinal pigment epithelium (RPE)
age of the nasal folded retina in (F′). Immunoﬂuorescence for Pax6 (green) (G),
compound mutant retinas. Scale bar in (A) corresponds to 50 μm and applies for
V. Fotaki et al. / Developmental Biology 380 (2013) 299–313 309at the periphery (Fig. 7B′), while Lef1 is observed throughout the
fold (Fig. 7D′).
We then examined the number and distribution of Wnt/
β-catenin responsive cells, by performing immunohistochemistry
for β-gal on the same control and mutant sections used for the
in situ hybridizations described above. The total number of β-gal-
positive cells in temporal and nasal CM combined showed a 5-fold
increase in the mutants compared to controls (Fig. 8A). In controls,
the majority of β-gal-positive cells detected were located in the
temporal CM, either within the tips of the CM (Wnt2b- and
Lef1-positive domains) or the broader CM area (Wnt2b-negative,
Lef1-positive domains), with only very few detected nasally
(compare Fig. 7A and C to A′ and C′ respectively and black bar to
dark grey bar in Fig. 8B). In mutants, although the number of β-gal-
positive cells in the temporal CM was higher than in controls, the
difference did not reach statistical signiﬁcance (compare Fig. 7A′ to
B′′, C′ to D′′, and dark grey to light grey bar in Fig. 8B). However, the
number of mutant β-gal-positive cells in nasal CM was 46-fold
higher compared to controls (compare Fig. 7A to B′, C to D′ and
black bar to white bar in Fig. 8B). Both nasally and temporally,
mutant β-gal-positive cells were found within a Wnt2b-, Lef1-
positive domain or a Wnt2b-negative, Lef1-positive domain
(Fig. 7B–B′′ and D–D′′).
A similar signiﬁcant increase in β-gal-positive cells was also
observed in E14.5 BAT-gal+;Foxg1−/− mutants (data not shown).
As with the E12.5 sections this increase in mutants was attributed
to an increase in nasally located CM cells. The majority of β-gal-
positive cells for both groups was located in the most dorsal
sections of the retina (not shown).
To corroborate the upregulation of Wnt/β-catenin signalling in
the Foxg1−/− mutant retinas, we performed immunohistochemistry
for Lef1, a downstream target of this pathway. Lef1 protein was
detected at high levels in the nasal and temporal CM of controls
(Fig. 7E,E′) and Foxg1−/− mutants (Fig. 7F) and in the nasal folds of
mutants (Fig. 7F′). Cell counts of Lef1 immunopositive cells
revealed a signiﬁcant increase in the number of labelled cells in
the nasal retina in mutants compared to controls (Fig. 8C), in
agreement with the results obtained with β-gal.
It has previously been reported that upregulation of Wnt/
β-catenin signalling in the mouse retina resulted in an increase
in CM cell fates at the expense of NR fates. However, in that study
the abnormally expanded CM region failed to express Pax6
(Liu et al., 2007), which is normally expressed by all cells in the
retina, including the CM (Davis-Silberman et al., 2005). To examine
whether the increased β-gal-positive cells in the compound
BAT-gal+;Foxg1−/− mutants also fail to express Pax6, we performed
double immunoﬂuorescence for these two proteins. Confocal
microscopy revealed that in our model of Wnt/β-catenin upregu-
lation, all CM β-gal-positive cells also express Pax6 (Fig. 7G I).
In summary, our results show an increase in Wnt/β-catenin
signalling in the Foxg1−/− CM, which is more pronounced in the
nasal peripheral retina.Discussion
Nasal retinal malformations in the Foxg1−/− mutant
It has been shown previously that the Foxg1−/− mutant eye
displays severe defects in its most ventral components, where
Foxg1 is strongly expressed early in development. The optic stalk
fails to form and the eye joins to the brain via an elongated retina.
In addition, the choroid ﬁssure does not form ventrally, leading to
a large ventral coloboma (Huh et al., 1999). Here, we characterised
in detail how loss of Foxg1 affects the retinal phenotype of Foxg1−/−
mutants. We observed that, starting at E11.5, retinal tissue expandsprogressively and forms folds that become very pronounced by
E14.5. These defects are prominent in the nasal retina where levels
of Foxg1 expression are normally highest.
Expanded tissue in the Foxg1−/− mutants has CM character
By studying the expression of several molecular markers we
concluded that much of the nasally expanded retinal tissue in the
Foxg1−/− mutant has CM identity. The markers used included Sfrp2,
Sox2 and Cyclin D1, which are all expressed in the entire retina
except for the CM (Liu et al., 2007, 2003; Matsushima et al., 2011;
Taranova et al., 2006), the CM markers Mitf (Horsford et al., 2005),
Otx1 (Martinez-Morales et al., 2001; Trimarchi et al., 2009), Msx1
(Monaghan, et al., 1991) and GFP expressed in CM at E14.5 following
activation of a GFP-reporter by Gsh2-cre (Kessaris et al., 2006).
Previous work described expansion of the CM in Sox2−/− mutant
mice (Matsushima et al., 2011). Inverse gradients of expression of
Sox2 in the central retina and Pax6 in the periphery normally
establish the boundary between the neurogenic and non-
neurogenic retinal components respectively. Genetic ablation of
Sox2 in mice results in cell fate conversion of the neural retina to
CM, indicating that Sox2 is required for neural competence in the
retina (Matsushima et al., 2011). Our ﬁndings indicate that Foxg1 also
contributes to the suppression of CM fates, with its greatest effects in
regions where its expression is normally highest. Unlike the effect of
losing Sox2, however, many cells of the optic cup retain their retinal
phenotypes, even in the nasal regions of Foxg1−/− mutants, as shown
for example by expression of the retinal progenitor marker Vsx2.
Foxg1 appears to play a more subtle role compared to that of Sox2,
perhaps suppressing the likelihood that cells outside the normal CM
will develop a CM identity. Such an action might explain why
additional ectopic CM regions develop in Foxg1−/− mutants, often at
a distance from the normal site of the CM (Fig. 9).
Foxg1 antagonises Wnt/β-catenin signalling in the developing retina
and CM
It is well established that the Wnt/β-catenin pathway plays
a crucial role in specifying peripheral fates of the eye in both chicks
and mice (Cho and Cepko, 2006; Esteve et al., 2011; Fuhrmann et al.,
2009; Kubo et al., 2003; Liu et al., 2006, 2007). In the chick retina,
in vivo activation of the Wnt/β-catenin pathway induced the
formation of ectopic structures with CM character, leading to loss
of retinal identity. Conversely, in vivo inhibition of the pathway led
to a reduction in the CM, highlighting the fact that loss-of-function
yielded results complementary to gain-of-function (Cho and Cepko,
2006). Similar to the chick, a stabilized form of β-catenin in an
in vivo mouse model led to increased CM development, an effect
that was more pronounced nasally (Liu et al., 2007). In addition,
conditional ablation of β-catenin in the peripheral retina reduced
the size of the CM (Liu et al., 2007). In agreement with this, based
on absence of CM fates and expansion of the neural retina in Sfrp1−/−
;Sfrp2−/− double mutants, it has recently been proposed that the
secreted frizzled-related proteins Sfrp1 and Sfrp2 ﬁne tune Wnt/
β-catenin signalling and cooperate to establish the border between
the peripheral and central neural retina (Esteve et al., 2011).
Considering the above, the expansion of CM sites in the Foxg1−/−
mutant retina may result from an upregulation of the Wnt/
β-catenin pathway, particularly in the nasal retina where Foxg1 is
normally most highly expressed as proposed in Fig. 9. Thus, an
additional role of Foxg1 in the embryonic eye may normally be to
restrict the development of the CM by suppressing this signalling
pathway. This is further supported by the fact that Foxg1 has been
shown to repress Wnt/β-catenin signalling in the developing zebra-
ﬁsh forebrain, setting the boundaries between dorsal and ventral
telencephalon as well as telencephalon and hypothalamus (Danesin
Fig. 8. Cell counts for immunopositive cells for downstream targets of the Wnt/β-catenin pathway. Counts for total number of β-gal-positive cells (A) and β-gal-positive
cells in the nasal and temporal retina (B). Counts for Lef1-positive cells in the nasal retina (C). Bars represent the median value of cell counts from at least 3 different retinas
per genotype (Mann–Whitney test). Error bars indicate standard deviation.
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β-catenin signalling expressed throughout the CM (Liu et al., 2006),
was more abundant in the Foxg1−/− peripheral retina than in that of
controls, and was observed in nasally formed folds with CM
identity.
Our compound Foxg1−/− mutant embryos carrying a BAT-gal
allele, which reports on Wnt/β-catenin signalling, allowed us to
further characterise changes in this pathway and quantify our
results. This Wnt-responsive model has been recently used to
study in detail Wnt signalling in the neighbouring RPE, but not the
retina (Fujimura et al., 2009; Westenskow et al., 2009). Similar
reporters have been used to study Wnt/β-catenin signalling in the
embryonic retina using X-gal staining (Fuhrmann et al., 2009; Liu
et al., 2003, 2007). Because β-gal is targeted to the nucleus in the
BAT-gal mouse (Maretto et al., 2003), we were able to quantify
Wnt-responsive cells by immunohistochemistry. In contrast to
previous reports (Fuhrmann et al., 2009; Liu et al., 2007), we did
not observe any Wnt-responsive cells in control central retina.This may be the result of the BAT-gal mouse under-reporting on
Wnt signalling or context-dependent discrepancies between the
different reporter mice (Barolo, 2006; Westenskow et al., 2009).
With our experimental approach we detected signiﬁcantly
more Wnt-responsive cells in the temporal than in the nasal CM
of controls, indicating that the Wnt/β-catenin pathway is normally
more active temporally than nasally. This raises the possibility that
this signalling cascade may not be the principal pathway that
normally determines CM speciﬁcation nasally, or that suppression
of this pathway is necessary for normal nasal CM development.
It also suggests that speciﬁcation of the nasal and temporal CM is
controlled by different molecular programmes. A plausible addi-
tional candidate for normal nasal CM speciﬁcation is Bmp signal-
ling, which has been implicated in ciliary body formation (Zhao
et al., 2002) (Fig. 9).
Regarding the compound BATgal+;Foxg1−/− mutants, we
observed an upregulation in the number of Wnt/β-catenin respon-
sive cells nasally, indicating that loss of Foxg1 has a striking effect
Fig. 9. Schematic diagram of the proposed role of Foxg1 in CM development.
Graded expression of Foxg1 in the retina is shown in grey with a strong grey shade
in the nasal and a lighter one in the temporal component of a wild type (Foxg1+/+)
where Foxg1 normally represses the Wnt/β-catenin signalling pathway in the nasal
CM (A). Speciﬁcation of the temporal CM may require the Wnt/β-catenin and/or the
Bmp signalling pathways. Foxd1, depicted in graded blue, may restrict expansion of
temporal CM fates (A). The high-to-low gradient of expression of Sox2 and that of
low-to-high of Pax6 from the central to the peripheral retina are shown in shades
of red and purple respectively (A). The yellow shade depicts expression of the
central retina markers Sfrp2 and Cyclin D1 examined in this study (A). The CM
markers studied are represented in brown in both the wild type (A) and mutant
(Foxg1−/−) (B). In the mutant, Wnt/β-catenin signalling is upregulated and the nasal
retina is expanded abnormally (B). (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
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development nasally? Our in situ hybridisation results demon-
strate high levels of Foxg1 expression in the nasal retina and CM
and lower levels in the corresponding temporal structures of
controls. Based on our experimental results we propose that,
nasally, Foxg1 normally represses Wnt/β-catenin signalling,
restricting CM expansion (Fig. 9). In the temporal CM, where low
levels of Foxg1 are present, this pathway remains active. Our
results also suggest that another molecule normally restricts CM
size expansion in the temporal peripheral retina. A likely candi-
date is the transcription factor Foxd1. This is based on its expres-
sion in the ventrotemporal peripheral retina (Carreres et al., 2011)and the fact that in both mouse and chick, Foxd1 and Foxg1 act
antagonistically to promote speciﬁcation of the temporal and nasal
molecular properties of the retina respectively, which are neces-
sary for proper formation of RGC projections (Herrera et al., 2004;
Takahashi et al., 2009, 2003; Tian et al., 2008) (Fig. 9).
Our in vivo model, summarised in Fig. 9, proposes that loss of
function of Foxg1 leads to over-expression of the Wnt/β-catenin
signalling pathway and to an increase in the size of CM tissue in
the peripheral retina. Foxg1 is a transcriptional repressor (Marcal
et al., 2005; Yao et al., 2001), but at present we can only speculate
as to which component of the pathway it suppresses in the
peripheral retina. Similar to wnt8b, a direct target of foxg1 in the
zebraﬁsh telencephalon (Danesin et al., 2009), Foxg1 may bind to
Wnt2b, the distal promoter of which contains two binding fork-
head domains for members of the FOX family of transcription
factors (Katoh, 2009). However, a recent report has argued against
Wnt2b being the modulator of Wnt/β-catenin signalling in the
mouse peripheral retina and proposes for this role the combina-
torial actions of Sfrp1 and Sfrp2 (Esteve et al., 2011).
Another possibility is that Foxg1 represses one (or more) of the
downstream targets of the Wnt/β-catenin pathway expressed in
the peripheral retina, such as Lef1, Tcf1, Tcf3 and Axin2 (Liu et al.,
2006). To date there is no direct evidence for such transcriptional
control. However, the fact that Foxg1 interacts with members of
the Groucho/TLE family of co-repressors (Roth et al., 2010;
Sonderegger and Vogt, 2003; Yao et al., 2001), which bind to
TCF/LEF sites repressing Wnt/β-catenin signalling transcription
(Levanon et al., 1998; Roose et al., 1998), raises the possibility that
Foxg1 may also participate in this inhibitory complex. Foxg1 may
also bind to β-catenin in the cytoplasm, where it is known to
localise in differentiating cells (Regad et al., 2007), inhibiting its
translocation to the nucleus and subsequent activation of down-
stream targets of the pathway.Conclusions
In this report, we examine the Foxg1−/− retinal phenotype and
ﬁnd an expansion of CM tissue, which is more pronounced in nasal
retina where Foxg1 is normally expressed at high levels. Our Wnt/
β-catenin signalling reporter mouse reveals that in controls this
pathway is mainly active in the temporal CM, while in Foxg1−/−
mutants it is over-activated nasally. This suggests that Foxg1
restricts CM expansion nasally, while a molecule other than Foxg1
plays an analogous role in the temporal CM. Our data are in
agreement with a new role of Foxg1 in restricting the develop-
ment of the CM nasally and establishing the boundary between
the neurogenic and the non-neurogenic retina.Funding source
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